Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Draeger's updated EvitaXL ventilator

This article was originally published in Clinica

Executive Summary

Draeger Medical, of Telford, Pennsylvania, has extended the capabilities of its EvitaXL ventilator with the addition of the SmartCare/PS option. The new option, which has just been approved by the FDA via the 510(k) route, automates the otherwise labour-intensive process of weaning patients from the ventilator by continually adjusting ventilatory support in response to clinical parameters and patients' respiratory profiles. In clinical trials, the PS option cut the time needed to wean patients by 40%, reduced the overall time spent on mechanical ventilation by 33%, and decreased the length of stay in the ICU by 20%. Draeger has also unveiled a new version of its Infinity Omega patient monitor featuring a widescreen touch-sensitive monitor. The system can simultaneously display real-time monitoring and ventilation data and networked data such as lab results or X-ray images. In addition, through the Infinity Network, data can also be displayed at a central monitoring station.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel